Plasma B‐type natriuretic peptide levels in children with heart disease

Aim: To determine plasma B‐type natriuretic peptide (BNP) levels in children with heart diseases before medical or surgical treatment for monitoring therapeutic efficacy in an observational prospective clinical trial at tertiary care centre. Methods: In 522 paediatric patients at an age of 6.4 ± 5.2 years (mean ± SD; range: 14 days–18 years) with congenital heart disease (CHD), cardiomyopathies (CMP) or pulmonary arterial hypertension (PAH),...